RIGL icon

Rigel Pharmaceuticals
RIGL

Overview Fund Activity

118 hedge funds and large institutions have $143M invested in Rigel Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 32 increasing their positions, 46 reducing their positions, and 12 closing their positions.

Holders
118
Holders Change
-6
Holders Change %
-4.84%
% of All Funds
1.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
32
Reduced
46
Closed
12
Calls
$1.13M
Puts
$122K
Net Calls
+$1M
Net Calls Change
+$257K

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$4.98M
2
Assenagon Asset Management
2
Assenagon Asset Management
Luxembourg
$4.68M
3
SCM
3
Soleus Capital Management
Connecticut
$18.3M
4
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$5.91M
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$1M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$259K
2
DZ Bank
2
DZ Bank
Germany
$0
3
RPAM
3
Rhenman & Partners Asset Management
Sweden
$327K
4
TA
4
Tamarack Advisers
California
$1.61M
5
Millennium Management
5
Millennium Management
New York
$5.8M
Name Holding Trade Value Shares
Change 		Shares
Change %
TCWA
126
Ten Capital Wealth Advisors
Washington
– -$2.64K -200 Closed
Point72 Asset Management
127
Point72 Asset Management
Connecticut
– -$991 -75 Closed
IAIM
128
International Assets Investment Management
Florida
– -$94 -7 Closed
Man Group
129
Man Group
United Kingdom
– -$189K – –
2 3 4 5
6